Operating Lease, Liability of Keros Therapeutics, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Keros Therapeutics, Inc. quarterly Operating Lease, Liability in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
Keros Therapeutics, Inc. Operating Lease, Liability for the quarter ending 31 Dec 2025 was $16,883,000, a 10% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

Keros Therapeutics, Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$16,883,000	-$1,978,000	-10%	31 Dec 2025	10-K	04 Mar 2026	2025	FY
Q4 2024	$18,861,000	+$4,417,000	+31%	31 Dec 2024	10-K	26 Feb 2025	2024	FY
Q3 2024	$19,286,000	+$4,971,000	+35%	30 Sep 2024	10-Q	06 Nov 2024	2024	Q3
Q4 2023	$14,444,000	+$1,178,000	+8.9%	31 Dec 2023	10-K	28 Feb 2024	2023	FY
Q3 2023	$14,315,000			30 Sep 2023	10-Q	06 Nov 2023	2023	Q3
Q2 2023	$13,951,000			30 Jun 2023	10-Q	07 Aug 2023	2023	Q2
Q1 2023	$13,994,000			31 Mar 2023	10-Q	04 May 2023	2023	Q1
Q4 2022	$13,266,000	+$12,173,000	+1114%	31 Dec 2022	10-K	03 Mar 2023	2022	FY
Q4 2021	$1,093,000	+$194,000	+22%	31 Dec 2021	10-K	09 Mar 2022	2021	FY
Q3 2021	$1,296,000			30 Sep 2021	10-Q	04 Nov 2021	2021	Q3
Q4 2020	$899,000			31 Dec 2020	10-K	25 Mar 2021	2020	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.